Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017

Summary

Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to prevent an application for a new drug from being considered ineligible for approval because its labeling includes information describing abuse-deterrent properties that otherwise would be blocked by market exclusivity provisions. The Department of Health and Human Services shall issue draft guidance and publish final guidance regarding the award and scope of exclusivity for new drugs with properties designed to deter abuse and the exceptions to such exclusivity. The bill applies to applications and supplements to applications that are submitted or pending approval on or after January 1, 2017.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 6 April 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 6 April 2017

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 6 April 2017

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.